Cargando…

In vitro immunogenic profile of recombinant SARS-CoV2 S1-RBD peptide in murine macrophage and microglial cells

BACKGROUND: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can infect common mice inducing significant pathological lung lesions and inflammatory responses. This substantially mimics coronavirus disease 19 (COVID-19) infection and pathogenesis in humans. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaves, Adriano José Maia, Jucá, Paloma Marinho, Soares, Michelle Verde Ramo, de Oliveira, Caio Andrade, de Sousa, Raul Cavalcante, Lós, Deniele Bezerra, Russo, Remo Castro, Yaochite, Juliana Navarro Ueda, Macedo, Danielle S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065410/ https://www.ncbi.nlm.nih.gov/pubmed/37018795 http://dx.doi.org/10.1590/0074-02760220144

Ejemplares similares

Decrease in cognitive performance and increase of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with higher doses of antipsychotics in women with schizophrenia: a cross-sectional study
por: Frota, Ilgner Justa, et al.
Publicado: (2023)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice
por: Govea-Alonso, Dania O., et al.
Publicado: (2022)

Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptide-based immunogen In vivo
por: Yadav, Naveen, et al.
Publicado: (2021)

Salivary anti-PGL-1 IgM may indicate active transmission of Mycobacterium leprae among young people under 16 years of age
por: Macedo, Alexandre Casimiro de, et al.
Publicado: (2017)

Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)

Immunogenicity and safety of a RBD vaccine against SARS-CoV-2 in a murine model
por: Díaz, Andrés, et al.
Publicado: (2022)

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
por: Dormeshkin, Dmitri, et al.
Publicado: (2023)

Assessment of electrical activity in the supra and infra hyoid muscle in individuals with type 2 diabetes mellitus
por: Santos, Tiago Lima, et al.
Publicado: (2015)

Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
por: Choque-Guevara, Ricardo, et al.
Publicado: (2022)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
por: Pan, Xiaoyan, et al.
Publicado: (2021)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
por: Leal, Lorna, et al.
Publicado: (2023)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice
por: Mabrouk, Moustafa T., et al.
Publicado: (2021)

Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2
por: Zhang, Zhikai, et al.
Publicado: (2022)

Recombinant expression of SARS-CoV-2 receptor binding domain (RBD) in Escherichia coli and its immunogenicity in mice
por: Rahbar, Zahra, et al.
Publicado: (2022)

Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2
por: Rodrigues, Kristen A., et al.
Publicado: (2021)

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Evaluating the immunogenicity of gold nanoparticles conjugated RBD with Freund's adjuvant as a potential vaccine against SARS-CoV-2
por: Moshref Javadi, Mahtab, et al.
Publicado: (2022)

Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
por: Pasquevich, Karina A., et al.
Publicado: (2023)

Shield effect of resistance jumping training on biomechanical parameters in gastrocnemius muscles of diabetic animals
por: Lós, Deniele Bezerra, et al.
Publicado: (2015)

Sildenafil Alleviates Murine Experimental Autoimmune Encephalomyelitis by Triggering Autophagy in the Spinal Cord
por: Duarte-Silva, Eduardo, et al.
Publicado: (2021)

α-Hemolysin-Aided Oligomerization of the Spike Protein RBD Resulted in Improved Immunogenicity and Neutralization Against SARS-CoV-2 Variants
por: Zou, Jintao, et al.
Publicado: (2021)

The Influence of Adjuvant Type on the Immunogenicity of RBD/N Cocktail Antigens as a Vaccine Candidate against SARS-CoV-2 Virus
por: Brzuska, Gabriela, et al.
Publicado: (2023)

Distinct metabolic patterns during microglial remodeling by oleate and palmitate
por: Chausse, Bruno, et al.
Publicado: (2019)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice
por: Nanishi, Etsuro, et al.
Publicado: (2023)

A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models
por: Sun, Chunyun, et al.
Publicado: (2023)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023)

Cashew apple juice as microbial cultivation medium for non-immunogenic hyaluronic acid production
por: Oliveira, Adriano H., et al.
Publicado: (2014)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
por: Lanza, Giuseppe, et al.
Publicado: (2022)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Behavior of fast and slow myosin in diabetic rats submitted to resistance power exercise
por: da Silva Nery, Cybelle, et al.
Publicado: (2015)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody
por: Meng, Xianmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nkba1dvtmh6p0bbd6h82lie6cp